Arrowhead Chairman Dr. Given to retire; Sarepta CEO Ingram expected to join board

ARROWHEAD PHARMACEUTICALS, INC.

Dr. Douglass Given retires from Board effective Dec 31, 2024, after 14 years as Chairman.
Douglas S. Ingram, President and CEO of Sarepta Therapeutics, expected to join Board in Q1 2025.
Ingram's appointment aligns with closing of Arrowhead-Sarepta Exclusive License and Collaboration Agreement (Nov 25, 2024).
Company expresses gratitude for Dr. Given's service.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.